Exploring Challenges And Future Perspectives For Minimal Residual Disease Mrd In Multiple Myeloma
Exploring Challenges And Future Perspectives For Minimal Residual Disease Mrd In Multiple Myeloma reveals several interesting facts.
- Bruno Paiva, PhD of the University of Navarra, Pamplona, Spain gives an overview of his talk on immunophenotyping for
- Minimal Residual Disease
- Ola Landgren, MD, PhD, from the Memorial Sloan Kettering Cancer Center, New York, NY, discusses how
- This video is part of the HMP Education content archive and may include previously accredited educational material. While this ...
- In this video, Dr. Ola Landgren talks about
In-Depth Information on Challenges And Future Perspectives For Minimal Residual Disease Mrd In Multiple Myeloma
Irene Ghobrial, MD from Dana-Farber Cancer Institute, Boston, MA, chairs a discussion on the detection of Bruno Paiva, PhD, University of Navarra, Pamplona, Spain, discusses the key Ola Landgren, MD, PhD, from the Memorial Sloan Kettering Cancer Center, New York, NY, explains that Watch this patient-friendly animated video that explains the most important concepts for patients on
MRD
Stay tuned for more updates related to Challenges And Future Perspectives For Minimal Residual Disease Mrd In Multiple Myeloma.